Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?

Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?

Source: 
Forbes
News Tags: 
snippet: 


More than 115 biotech companies have announced layoffs this year, on track to easily surpass 2022’s numbers. While this is not a new trend, the current trajectory is concerning, as it portends more difficult times ahead for the pharmaceutical industry–already in the midst of a major upheaval. It should also be another wake-up call to pharma executives: the old way of doing business needs to change–and urgently.